Text Search >
2\\\\\\\'-Deoxyguanosine+hydrate
Print…
You Searched For:
49,759 results were found
2\\\\\\\'-Deoxyguanosine+hydrate
Catalog Number:
(PI22582)
Supplier:
Invitrogen
Description:
Thermo Scientific Pierce Ellman's Reagent (DTNB) reacts with sulfhydryl groups to yield a colored product, providing a reliable method to measure reduced cysteines and other free sulfhydryls in solution.
Supplier:
TCI America
Description:
CAS Number: 553-26-4
MDL Number: MFCD00006416 Molecular Formula: C10H8N2 Molecular Weight: 156.19 Purity/Analysis Method: >98.0% (GC,T) Form: Crystal Boiling point (°C): 161 Melting point (°C): 112 Lambda max.: 300 nm (CH3CN)
Catalog Number:
(TS39787-0500)
Supplier:
THERMO FISHER SCIENTIFIC CHEMICALS
Description:
Milrinone 97%
Supplier:
TCI America
Description:
CAS Number: 111-21-7
MDL Number: MFCD00026213 Molecular Formula: C10H18O6 Molecular Weight: 234.25 Purity/Analysis Method: >98.0% (GC) Form: Clear Liquid Color: Colorless Boiling point (°C): 300 Flash Point (°C): 174 Specific Gravity (20/20): 1.12
Catalog Number:
(77625-942)
Supplier:
AMBEED, INC
Description:
AZD0780 98%
Supplier:
THERMO FISHER SCIENTIFIC CHEMICALS
Description:
Ethyl viologen dibromide 97%
Catalog Number:
(103328-102)
Supplier:
Novus Biologicals
Description:
The HLA DMB Antibody (4D12) from Novus Biologicals is a mouse monoclonal antibody to HLA DMB. This antibody reacts with human. The HLA DMB Antibody (4D12) has been validated for the following applications: Western Blot, ELISA, Immunoprecipitation.
Catalog Number:
(103328-092)
Supplier:
Novus Biologicals
Description:
The HLA DMB Antibody (2D3) from Novus Biologicals is a mouse monoclonal antibody to HLA DMB. This antibody reacts with human. The HLA DMB Antibody (2D3) has been validated for the following applications: Western Blot, ELISA, Immunocytochemistry / Immunofluorescence.
Catalog Number:
(77616-752)
Supplier:
AMBEED, INC
Description:
1,1'-Diphenyl-4,4'-bipyridinium dichloride ≥97%
Catalog Number:
(TCD2165-001G)
Supplier:
TCI America
Description:
CAS Number: 47369-00-6
MDL Number: MFCD00142355 Molecular Formula: C22H18Cl2N2 Molecular Weight: 381.30 Purity/Analysis Method: >97.0% (HPLC,T) Form: Crystal
Supplier:
Thermo Scientific Chemicals
Description:
Fieser: 1,1046 3,261 4,442 6,529 7,329 12,441 18,332 20,349 21,401
Catalog Number:
(89351-242)
Supplier:
Genetex
Description:
BRCA1 (breast and ovarian cancer susceptibility protein 1) is a RING finger protein containing a BRCT domain. BRCA1 exists as a heterodimer with 22 possible isoforms. The full length protein has a reported molecular weight of 208 kD. BRCA1 localizes to the mitotic spindle microtubules, centriole walls, pericentriolar fibers at centrosomes. Unphosphorylated BRCA1 localizes on chromosomes from metaphase through telophase; phosphorylated BRCA1 resides in inner chromosomal structure, centrosome, cleavage furrow during prophase through telophase, and relocalizes to the perinuclear region when cells are subjected to IR or UV radiation in S phase. BRCA1 acts as a tumor suppressor and can function as a secreted growth inhibitory protein, participate in transcription coupled repair of oxidative DNA damage, X-chromosome inactivation, and can function as a E3 ubiquitin ligase. BRCA1 can be transcriptionally downregulated by Ets-2, Brg-1, and Hmga-1. BRCA1 can be modified by glycosylation, ubiquitination and phosphorylation by CDK4, ATM/ATR, cdk2, and hChk2. The BRCA1 protein has been reported to interact with RNA polymerase II holoenzyme and BARD1. BRCA1 contains at least two nuclear localization signals and is proposed to be a tumor suppressor protein. It is a serine phosphoprotein that undergoes hyperphosphorylation during late G1 and S phases of the cell cycle and is transiently dephosphorylated early after M phase. BRCA1 protein alters in a qualitative and quantitative manner during cell cycle progression. The amount of BRCA1 protein is highest during S phase and remains elevated toward G2 / M, before it declines in early G1 phase. Inherited loss of BRCA1 function confers an increased susceptibility for both breast and ovarian cancer.
Catalog Number:
(82022-846)
Supplier:
G-Biosciences
Description:
Ellman's reagent is a versatile, water-soluble compound for quantifying free sulfhydryl groups in solution. It reacts with a free sulfhydryl group to yield a mixed disulfide and 2-nitro-5-thiobenzoic acid (NTB), a measurable yellow colored product at 412nm.
Ellman's reagent is very useful as a free sulfhydryl assay reagent due to its high specificity for -SH groups at neutral pH, high molar extinction coefficient and short reaction time.
Catalog Number:
(TCD1593-005G)
Supplier:
TCI America
Description:
[for Electrochromic Material]
CAS Number: 6159-05-3 MDL Number: MFCD00011997 Molecular Formula: C24H38Br2N2 Molecular Weight: 514.39 Purity/Analysis Method: >98.0% (HPLC,T) Form: Crystal
Catalog Number:
(89351-244)
Supplier:
Genetex
Description:
BRCA1 (breast and ovarian cancer susceptibility protein 1) is a RING finger protein containing a BRCT domain. BRCA1 exists as a heterodimer with 22 possible isoforms. The full length protein has a reported molecular weight of 208 kD. BRCA1 localizes to the mitotic spindle microtubules, centriole walls, pericentriolar fibers at centrosomes. Unphosphorylated BRCA1 localizes on chromosomes from metaphase through telophase; phosphorylated BRCA1 resides in inner chromosomal structure, centrosome, cleavage furrow during prophase through telophase, and relocalizes to the perinuclear region when cells are subjected to IR or UV radiation in S phase. BRCA1 acts as a tumor suppressor and can function as a secreted growth inhibitory protein, participate in transcription coupled repair of oxidative DNA damage, X-chromosome inactivation, and can function as a E3 ubiquitin ligase. BRCA1 can be transcriptionally downregulated by Ets-2, Brg-1, and Hmga-1. BRCA1 can be modified by glycosylation, ubiquitination and phosphorylation by CDK4, ATM/ATR, cdk2, and hChk2. The BRCA1 protein has been reported to interact with RNA polymerase II holoenzyme and BARD1. BRCA1 contains at least two nuclear localization signals and is proposed to be a tumor suppressor protein. It is a serine phosphoprotein that undergoes hyperphosphorylation during late G1 and S phases of the cell cycle and is transiently dephosphorylated early after M phase. BRCA1 protein alters in a qualitative and quantitative manner during cell cycle progression. The amount of BRCA1 protein is highest during S phase and remains elevated toward G2 / M, before it declines in early G1 phase. Inherited loss of BRCA1 function confers an increased susceptibility for both breast and ovarian cancer.
Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the
 is still displayed and you need assistance, please call us at 1-800-932-5000.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the
is still displayed and you need assistance, please call us at 1-800-932-5000.
This product is marked as restricted and can only be purchased by approved Shipping Accounts. If you need further assistance, email VWR Regulatory Department at Regulatory_Affairs@vwr.com
-Additional Documentation May be needed to purchase this item. A VWR representative will contact you if needed.
This product has been blocked by your organization. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
This product is no longer available. Alternatives may be available by searching with the VWR Catalog Number listed above. If you need further assistance, please call VWR Customer Service at 1-800-932-5000.
|
|||||||||
List View
